MetaVia announces peer-reviewed study on vanoglipel for liver fibrosis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. ABBV
8. USO
9. IBM
10. META

Go back to MetaVia announces peer-reviewed study on vanoglipel for liver fibrosis
(NASDAQ: MTVA) Delayed: 1.57 --0 (-0%)
Previous Close $1.57    52 Week High $ 
Open $1.57    52 Week Low $ 
Day High $1.57    P/E N/A 
Day Low $1.57    EPS $ 
Volume 3,124